secwatch.observer — SEC 8-K summary
======================================

Issuer:     AYTU BIOPHARMA, INC (AYTU)
CIK:        0001385818
Form:       8-K
Filed at:   2023-01-25T23:59:59+00:00
Accession:  0001558370-23-000493
Event type: regulatory
Sentiment:  positive
Materiality: 0.50
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aytu BioPharma regains Nasdaq minimum bid price compliance
----------------------------------------------------------

- Received Nasdaq notification on Jan 23, 2023 confirming bid price compliance.
- Closing bid price exceeded $1.00 for 10 consecutive business days (Jan 6-20, 2023).
- Company is now fully compliant with all Nasdaq listing rules; matter closed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1385818/000155837023000493/0001558370-23-000493-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1385818/000155837023000493/aytu-20230123x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-000493

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer